4
Changes in Ownership
TScan Therapeutics, Inc. Filed Acc 0000950170-25-018119
Options or other derivatives
- Chief Medical Officer acquired 400,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Louis Chrystal Chief Medical Officer | 2025-01-03 | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…